AstraZeneca - ADR Financials

$178.76

up-down-arrow $-3.51 (-1.93%)

As on 18-Nov-2026 16:00EST

Market cap

info icon

$286,067 Mln

Revenue (TTM)

info icon

$62,168 Mln

P/E Ratio

info icon

26.1

P/B Ratio

info icon

5.5

Div. Yield

info icon

1.8 %

Income Statement ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Operating Revenue
62,168.16
58,739.00
54,073.00
45,811.00
44,351.00
37,417.00
Cost of Revenue
12,379.20
10,633.00
10,207.00
8,268.00
12,391.00
12,437.00
Gross Profit
49,788.95
48,106.00
43,866.00
37,543.00
31,960.00
24,980.00
Operating Expenses
35,080.26
34,363.00
33,863.00
29,350.00
28,203.00
23,924.00
Operating Profit (EBIT)
14,708.69
13,743.00
10,003.00
8,193.00
3,757.00
1,056.00
Other Income
--
--
--
--
--
--
Profit before Tax
13,247.29
12,402.00
8,691.00
6,899.00
2,501.00
-265.00
Provision for Tax
2,254.79
2,169.00
1,650.00
938.00
-792.00
-380.00
Profit after Tax (Net Income)
10,988.49
10,255.00
7,035.00
5,955.00
3,288.00
112.00
Minority Interest
-4.00
-8.00
-6.00
-6.00
-5.00
-3.00
Consolidated Profit
2,326.00
10,225.00
7,035.00
5,955.00
--
--

Liabilities ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Shareholder's Funds
51,636.49
48,667.00
40,786.00
39,143.00
37,037.00
39,268.00
Minority Interest
-4.00
52.00
85.00
23.00
21.00
--
Non-Current Liabilities
36,775.83
34,738.00
35,298.00
31,411.00
33,132.00
43,482.00
Current Liabilities
31,211.69
30,617.00
27,866.00
30,542.00
26,293.00
22,594.00
Total Liabilities
150,921.55
114,074.00
104,035.00
101,119.00
96,483.00
105,363.00

Assets ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Non-Current Assets
88,317.49
85,351.00
78,208.00
76,065.00
73,890.00
79,119.00
Current Assets
31,392.37
28,723.00
25,827.00
25,054.00
22,593.00
26,244.00
Total Assets
150,921.23
114,074.00
104,035.00
101,119.00
96,483.00
105,363.00
Total Debt*
34,130.52
29,703.00
30,114.00
28,622.00
29,143.00
30,688.00
Net Current Assets
181.00
-1,894.00
-2,039.00
-5,488.00
-3,700.00
3,650.00

Cashflow ($ Mln)

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Cash From Operating Activities
--
14,575.00
11,861.00
10,345.00
9,808.00
5,963.00
Cash Flow from Investing Activities
--
-6,808.00
-7,980.00
-4,064.00
-2,960.00
-11,058.00
Cash from Financing Activities
--
-7,544.00
-3,996.00
-6,567.00
-6,823.00
3,649.00
Net Cash Inflow / Outflow
--
--
--
--
--
--

Financials Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Adjusted EPS ($) info
7.04
6.57
4.50
3.81
2.11
0.07
Cash EPS ($) info
--
10.24
7.75
6.98
5.48
2.72
Adjusted Book Value ($) info
--
31.16
26.11
25.08
23.76
25.38
Dividend per Share ($) info
--
--
--
--
--
--
Cash Flow per Share ($) info
--
9.33
7.59
6.63
6.29
3.85
Free Cash Flow per Share ($) info
--
5.55
4.66
4.21
4.64
2.43

Profitability Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
ROCE (%) info
--
13.74
10.15
8.89
4.83
0.21
ROE (%) info
22.20
22.93
17.60
15.63
8.62
0.41
ROA (%) info
7.34
9.40
6.86
6.03
3.26
0.13
EBIT Margin (%) info
24.07
24.00
19.18
18.53
8.64
2.70
Net Margin (%) info
17.68
17.46
13.01
13.00
7.41
0.30
Cash Profit Margin (%) info
--
--
--
--
--
--

Growth Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Revenue Growth (%) info
6.95
0.09
0.18
0.03
0.19
0.41
EBIT Growth (%) info
14.31
35.89
22.21
121.56
278.93
-80.51
Net Profit Growth (%) info
16.93
45.77
18.14
81.11
2,835.71
-96.50
EPS Growth (%) info
16.91
0.46
0.18
0.81
28.13
-0.97
Book Value Growth (%) info
12.60
--
--
--
--
--

Valuation Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Price / Earnings info
26.09
14.00
14.55
17.65
32.15
804.58
Price / Book Value info
5.53
2.95
2.51
2.69
2.85
2.29
Dividend Yield (%) info
1.75
--
--
--
--
--
EV/EBITDA info
14.77
8.45
8.22
9.53
14.16
22.37
Close Price ($) info
161.47
91.93
65.52
67.35
67.80
58.25
High Price ($) info
212.71
94.02
87.68
76.56
71.70
64.21
Low Price ($) info
80.48
61.24
60.47
61.73
52.65
46.48
Market Cap ($ Cr) info
286,066.74
--
--
--
--
--

Solvency Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Debt to Equity info
0.51
0.61
0.74
0.73
0.79
0.78
Short term debt to equity ratio info
0.10
0.07
0.06
0.14
0.15
0.05
Current Ratio info
1.01
0.94
0.93
0.82
0.86
1.16
Quick Ratio info
0.79
0.72
0.74
0.64
0.68
0.76
Interest Coverage info
8.48
8.32
6.17
5.34
2.88
0.79

Operating Efficiency Ratios

TTM Dec-25 Dec-24 Dec-23 Dec-22 Dec-21 Dec-20 Dec-19 Dec-18 Dec-17 Dec-16
Debtors to sales (%) info
26.30
25.84
20.78
18.35
20.73
21.73
Asset Turnover info
0.42
0.54
0.53
0.46
0.44
0.43
Receivable days info
--
82.12
66.34
70.16
71.34
67.27
Inventory Days info
--
203.44
191.66
223.60
201.65
190.99
Payable days info
--
496.71
123.58
128.49
79.20
75.98
Cash Conversion Cycle info
--
-211.15
134.42
165.27
193.78
182.29
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...

Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.

Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month